Article
Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance.
Cancer medicine - 1 Nov 2022
Brady Lauren, Newcomb Lisa F, Zhu Kehao, Zheng Yingye, Boyer Hilary, Sarkar Navonil De, McKenney Jesse K, Brooks James D, Carroll Peter R, Dash Atreya, Ellis William J, Filson Christopher P, Gleave Martin E, Liss Michael A, Martin Frances, Morgan Todd M, Thompson Ian M, Wagner Andrew A, Pritchard Colin C, Lin Daniel W, Nelson Peter S
Abstract excerpt
BACKGROUND: Pathogenic germline mutations in several rare penetrant cancer predisposition genes are associated with an increased risk of aggressive prostate cancer (PC). Our objectives were to determine the prevalence of pathogenic germline mutations in men with low-risk PC on active surveillance, and assess whether pathogenic germline mutations associate with grade reclassification or adverse pathology,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
